First Mercantile Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,031
| Closed | -$117K | – | 891 |
|
|
2021
Q1 | $117K | Sell |
1,031
-121
| -11% | -$13.7K | 0.01% | 631 |
|
|
2020
Q4 | $159K | Sell |
1,152
-123
| -10% | -$17K | 0.02% | 519 |
|
|
2020
Q3 | $145K | Sell |
1,275
-53
| -4% | -$6.03K | 0.02% | 537 |
|
|
2020
Q2 | $104K | Sell |
1,328
-833
| -39% | -$65.2K | 0.01% | 649 |
|
|
2020
Q1 | $96K | Buy |
2,161
+274
| +15% | +$12.2K | 0.01% | 568 |
|
|
2019
Q4 | $81K | Sell |
1,887
-5
| -0.3% | -$215 | 0.01% | 728 |
|
|
2019
Q3 | $81K | Buy |
1,892
+741
| +64% | +$31.7K | 0.01% | 750 |
|
|
2019
Q2 | $73K | Buy |
1,151
+166
| +17% | +$10.5K | 0.01% | 707 |
|
|
2019
Q1 | $68K | Buy |
985
+495
| +101% | +$34.2K | 0.02% | 736 |
|
|
2018
Q4 | $21K | Sell |
490
-165
| -25% | -$7.07K | 0.01% | 854 |
|
|
2018
Q3 | $50K | Buy |
+655
| New | +$50K | 0.01% | 796 |
|
|
2017
Q1 | – | Sell |
-1,954
| Closed | -$137K | – | 852 |
|
|
2016
Q4 | $137K | Sell |
1,954
-385
| -16% | -$27K | 0.02% | 683 |
|
|
2016
Q3 | $166K | Buy |
2,339
+39
| +2% | +$2.77K | 0.02% | 641 |
|
|
2016
Q2 | $112K | Sell |
2,300
-2,505
| -52% | -$122K | 0.01% | 708 |
|
|
2016
Q1 | $304K | Buy |
4,805
+405
| +9% | +$25.6K | 0.04% | 530 |
|
|
2015
Q4 | $493K | Buy |
4,400
+1,005
| +30% | +$113K | 0.05% | 440 |
|
|
2015
Q3 | $327K | Buy |
3,395
+1,840
| +118% | +$177K | 0.03% | 565 |
|
|
2015
Q2 | $159K | Sell |
1,555
-2,015
| -56% | -$206K | 0.01% | 742 |
|
|
2015
Q1 | $222K | Buy |
3,570
+1,985
| +125% | +$123K | 0.02% | 675 |
|
|
2014
Q4 | $70K | Sell |
1,585
-1,705
| -52% | -$75.3K | 0.01% | 909 |
|
|
2014
Q3 | $186K | Buy |
+3,290
| New | +$186K | 0.02% | 734 |
|